Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
There has been substantial progress in preventing and treating CMV infection. Prophylaxis with CMV screened blood products, IVIG and antiviral drugs (high dose acyclovir and/or Ganciclovir) considerably reduce the incidence of CMV disease and nearly eliminate CMV pneumonia after allogeneic BMT.
Devergie
A
A
Service de Greffe de Moelle, Hôpital Saint Louis, Paris, France.
Traineau
R
R
Esperou-Bourdeau
H
H
Ribaud
P
P
Socié
G
G
Richard
P
P
Selimi
F
F
Hirsch
I
I
Gluckman
E
E
D000914:Antibodies, Viral / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D014184:Transplantation, Homologous
D000914:Antibodies, Viral